期刊
NATURE REVIEWS MICROBIOLOGY
卷 14, 期 5, 页码 273-287出版社
NATURE PUBLISHING GROUP
DOI: 10.1038/nrmicro.2016.17
关键词
-
类别
资金
- US National Institutes of Health [R01AT008618, R01HL122593, F32DK101154]
- Young Investigator Grant for Probiotics Research
- George Williams Hooper Research Foundation
- University of California San Francisco (UCSF) Department of Microbiology Immunology
- Damon Runyon Cancer Research Foundation [DRR-42-16]
Although the importance of human genetic polymorphisms in therapeutic outcomes is well established, the role of our 'second genome' (the microbiome) has been largely overlooked. In this Review, we highlight recent studies that have shed light on the mechanisms that link the human gut microbiome to the efficacy and toxicity of xenobiotics, including drugs, dietary compounds and environmental toxins. Continued progress in this area could enable more precise tools for predicting patient responses and for the development of a new generation of therapeutics based on, or targeted at, the gut microbiome. Indeed, the admirable goal of precision medicine may require us to first understand the microbial pharmacists within.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据